4D Molecular Therapeutics (4DMT) IPO

4DMT is a biotechnology company focused on pioneering the development of precision gene therapies based on proprietary AAV vectors.

Register for Details

For more details on financing and valuation for 4D Molecular Therapeutics (4DMT), register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is 4D Molecular Therapeutics (4DMT)'s ticker symbol?

FDMT

What is 4D Molecular Therapeutics (4DMT)'s stock price?

14.45 as of 9/21/23

Learn more about 4D Molecular Therapeutics (4DMT)

Forge green plus iconForge green minus icon

What is 4D Molecular Therapeutics (4DMT) funding to date?

4D Molecular Therapeutics (4DMT) has raised $109MM to date.
Forge green plus iconForge green minus icon

When was 4D Molecular Therapeutics (4DMT) founded?

4D Molecular Therapeutics (4DMT) was founded in 2013.
Updated on: Jun 12, 2022